The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Saakian S.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Zakharova G.P.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Miakoshina E.B.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava RF

Mast cells in the microenvironment of uveal melanoma

Authors:

Saakian S.V., Zakharova G.P., Miakoshina E.B.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2019;81(6): 63‑70

DOI: 10.17116/patol20198106163

Read: 2192 times

Download PDF (RU)
Contact the author
Table of contents

MAST CELLS IN THE MICROENVIRONMENT OF UVEAL MELANOMA
MAST CELLS IN THE MICROENVIRONMENT OF UVEAL MELANOMA

To cite this article:

Saakian SV, Zakharova GP, Miakoshina EB. Mast cells in the microenvironment of uveal melanoma. Russian Journal of Archive of Pathology. 2019;81(6):63‑70. (In Russ.)
https://doi.org/10.17116/patol20198106163

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Dermal mast cells density examination as an aspect of mechanical inju­ries vita­lity diagnostics. Fore­nsic Medi­cal Expe­rtise. 2024;(6):25-29
Uveal mela­noma and its local inflammation — good or bad for the patient?. Russian Annals of Ophthalmology. 2025;(1):5-12
Abstract:

Objective — to study the morphological features of the microenvironment of a tumor nodule in the eyes with uveal melanoma, focusing on mast cells. Material and methods. A total of 43 enucleated eyes with uveal melanoma (260 histological specimens) were examined. The patients’ age averaged 54±2.7 years. The morphopathological types of tumors were as follows: epithelioid-cell (n=9; 20.9%), spindle-cell type AB (n=15; 34.9%), and mixed-cell (n=19; 44.2%). The tumor prominence was 4.7±1.3 mm; the base diameter was 13.5±3.3 mm. Statistical methods, such as Microsoft Excel, Statistica 10.1, Spearman’s rank correlation coefficient (rs), were applied. Results. Mast cells in the microenvironment of uveal melanoma were present in 18 (41.9%) of the 43 eyes. There was a significantly higher correlation between the mixed-cell type of tumor and the accumulation of mast cells (rs=0.636). The correlation coefficient (rs) of the number of mast cells with the degree of tumor pigmentation in terms of densely and weakly pigmented forms was 0.571 and 0.717, respectively. Tumor invasion through the sclera was detected in 7 (16.3%) eyes with mast cells (rs=0.395). Tumor growth in the emissarium in the presence of mast cells was determined in 8 (18.6%) cases (rs=0.469). Comparison established a correlation between the number of mast cells and the sections of tumor blood vessels (rs=0.21). Granulated cells were noted in 15 (34.9%) cases; degranulated ones were seen in 3 (7%) cases of the 43 examined eyes. with an ejection of granules around the tumor cells, which may be evidence of their interaction. Granules were ascertained to be released around the tumor cells, which may be suggestive of their interaction. Conclusion. The study of the mast cell population as one of the components of the tumor microenvironment can be used to elaborate novel approaches for the targeted treatment of uveal melanoma, in particular for its impact on tumor angiogenesis, by using mast cell inhibitors. Therefore, it is relevant and promising to conduct further investigation of mast cells in uveal melanoma.

Keywords:

mast cells
microenvironment
uveal melanoma

Authors:

Saakian S.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Zakharova G.P.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Miakoshina E.B.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava RF

Close metadata

References:

  1. Brovkina AF, ed. Oftal’moonkologiya (Ophthalmooncology). Moscow: Meditsina; 2002. (In Russ.)
  2. Neroev VV, ed. Oftal’mologiya. Klinicheskie rekomendatsii (Ophthalmology. Clinical guidelines). Moscow: GEOTAR-Media, 2019. (In Russ.)
  3. Saakyan SV, Amiryan AG, Tsygankov AYu, Sklyarova NV, Zaletaev DV. Clinical, pathological and molecular genetic features of uveal melanoma with a high risk of metastasis. Rossiiskiy oftal’mologicheskiy zhurnal. 2015;8(2):47-52. (In Russ.)
  4. Myakoshina EB. Complex diagnostics of early choroidal melanoma. Rossiiskiy elektronnyi zhurnal luchevoy diagnostiki (Russian electronic journal of radiology). 2016;6(4):19-28. (In Russ.) https://doi.org/10.21569/2222-7415-2016-6-4-19-28
  5. Berezhnaya NM. The role of the immune system in the tumor microenvironment. I. Cells and cytokines — participants of inflammation. Onkologiya. 2009;11(1):6-17. (In Russ.)
  6. Mantovani A, Romero P, Palucka AK, Marincola FM. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet. 2008;371(9614):771-783.
  7. Fidler IJ, Kim SJ, Langley RR. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J. Cell Biochem. 2007;101(4):927-936.
  8. Borisov KE, Sakaeva DD. Tumor microenvironment as a target for the treatment of malignant gliomas. Diagnostika i lechenie opukholei. 2015;(4):14-23. (In Russ.) https://doi.org/10.18027/2224-5057-2015-4-14-23
  9. Ehrlich P. Beitrag zur Kenntnis der Anilinfar-bungen und ihrer Verwendung in der mikro-skopischen Technik. Arch mikr Anat. 1877; 13:263.
  10. Berezhnaya NM, Sepiashvili RI. Mast cells. Immunologiya i allergologiya. 2003;4(3):29-38. (In Russ.)
  11. Bykov VL. Secretory mechanisms and secretory products of mast cells. Morfologiya.1999;2:64-72. (In Russ.)
  12. Gutman M, Singh RK, Xie K, Bucana CD, Fiedler IJ. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res. 1995;55(11):2470-2475.
  13. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T-cells: juxtacrine regulation by TNF-alpha. J Immunol. 2001;167(7):4008-4016. https://doi.org/10.4049/jimmunol.167.7.4008
  14. Ribatti D, Crivellato E, Roccaro AM, Ria R, Vacca A. Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy. 2004;34(11):1660-1664. https://doi.org/10.1111/j.1365-2222.2004.02104.x
  15. Feoktistov I, Goldstein AE, Ryzhov S, Biaggioni I. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res. 2003;92(5):485-492. https://doi.org/10.1161/01.RES.0000061572.10929.2D
  16. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99(11):2691-2700. https://doi.org/10.1172/JCI119458
  17. Ch’ng S, Wallis R, Yuan L, Davis P, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19(1):149-159. https://doi.org/10.1038/modpathol.3800474
  18. Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008;112(4):1269-1279. https://doi.org/10.1182/blood-2008-03-147033
  19. Bi Y, Liu G, Yang R. Th17 cell induction and immune regulatory effects. J Cell Physiol. 2007;211(2):273-278. https://doi.org/10.1002/jcp.20973
  20. Terlikowski SJ, Nowak HF, Famulski W, Sulkowska M. Effect of the cytokine rhTNF-alpha on the population of mast cells in the growth of MethA fibrosarcoma-a TEM study. Folia Histochem Cytobiol. 2001;39(Suppl.2):199-200.
  21. Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, Sirigu P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 2003;33(5):420-425. https://doi.org/10.1046/j.1365-2362.2003.01152.x
  22. Bronkhorst IHG, Jager MJ. Inflammation in uveal melanoma. Eye (Lond). 2013;27(2):217-223.
  23. Krichevskaya GI, Slepova OS, Saakyan SV, Myakoshina EB, Andreeva TA, Andryushin AE, Khoroshilova IP, Zakharova GP, Maibogin AM, Trukhina AV. On the role of human herpes viruses in the pathogenesis of orbit and eye tumors: detection of viral DNA in biopsy specimens. Rossiiskiy oftal’mologicheskiy zhurnal. 2016;9(2):42-47. (In Russ.)
  24. Saakyan SV, Myakoshina EB, Krichevskaya GI, Slepova OS, Panteleeva OG, Andryushin AS, Khoroshilova-Maslova IP, Zakharova GP. Examination of patients with uveal melanoma for the presence of herpes viral infection. Voprosy virusologii. 2016;61(6):284-7. (In Russ.)
  25. Krichevskaya GI, Slepova OS, Saakyan SV, Myakoshina EB. The effect of herpes viral infections on the level of serum interferon-alpha and interferon is gamma in patients with the initial choroidal melanoma. Rossiiskii oftal’mologicheskii zhurnal. 2014;7(2):28-32. (In Russ.)
  26. Yang M, McKay D, Pollard WJ, Lewis CE. Diverse functions of macrophages in different tumor microenvironments. Cancer Res. 2018;78(19):5492-503. https://doi.org/10.1158/0008-5472.CAN-18-1367
  27. Pleshkan VV, Alekseenko IV, Tyulkina DV, Kyzmich AI, Zinovyeva MV, Sverdlov ED. Fibroblast activation protein FAP as a possible target of an antitumor strategy. Mol Gen Microbiol Virol. 2016;34(3):90-97. (In Russ.) https://doi.org/10.18821/0208-0613-2016-34-3-90-97
  28. Mnikhovich MV, Vernigorodskii SV, Gavrilyuk AA, Miglyas VG. Morphological assessment of changes in fat cell populations in the stroma of the breast in fibrocystic disease and cancer. Nauka molodykh (Eruditio Juvenium). 2014;1:26-36. (In Russ.)
  29. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13(10):1211-1218. https://doi.org/10.1038/nm1649
  30. Mukaratirwa S, Chikafa L, Dliwayo R, Moyo N. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors. Vet Dermatol. 2006;17(2):141-146. https://doi.org/10.1111/j.1365-3164.2006.00505.x Received 15.04.19
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.